Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine combined with oxycodone for postoperative analgesia in elderly abdominal surgery patients
ChiCTR2500100472Phase 4Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and oxycodone in postoperative pain (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoint: Incidence of moderate to severe pain within 72 hours postoperatively. Started Apr 2025; status: recruiting.
02
Drugs
esketamineoxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500100472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100472.